← FDA Drug Approvals (Drugs@FDA)

MILTOWN

NDA · New Drug Application · Sponsor: MEDPOINTE PHARM HLC · Approved 1955-04-28

Drug application

FDA Application #

NDA009698

Application type

New Drug Application

Brand name

MILTOWN

Generic name

Meprobamate

Active ingredients

MEPROBAMATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MEDPOINTE PHARM HLC

First approval

1955-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown